Janssen Pharmaceuticals

MeiraGTx is a clinical-stage genetic medicine company based in New York that is dedicated to unlocking the potential of genetic therapies for both rare and prevalent diseases. The company employs pioneering technologies, including a unique riboswitch gene regulation platform, to achieve precision control of gene expression, which can transform the treatment landscape for various disorders. With a commitment to improving patient lives, MeiraGTx integrates advanced science and an extensive manufacturing ecosystem to provide tailored treatments. Their diverse clinical pipeline reflects the company's focus on addressing inherited and non-inherited diseases through innovative approaches to genetic medicine. Generated from the website

Technovax Inc, located in Elmsford, NY, is a biotechnology company focused on developing innovative solutions in the field of bioservices and partnering opportunities. The company is dedicated to advancing its technologies and pipeline to meet the evolving needs of the industry. With a management team and advisory board comprised of experienced professionals, Technovax Inc aims to foster collaborations that enhance its research and development efforts. The company is committed to delivering high-quality services and products that contribute to the advancement of biotechnology. Generated from the website

Ayala Pharmaceuticals, Inc, based in Monmouth Junction, NJ, is a biopharmaceutical company focused on developing innovative therapies. In the first quarter of 2024, the company announced the acquisition of AL102 and AL101 by Immunome Inc. Additionally, Ayala Pharmaceuticals is involved with other products such as BST-236. The company's leadership and research efforts are oriented towards advancing treatment options in the medical field. Generated from the website